Phoenix Biotechnology
Pre-clinicalDevelops botanical drug candidates for cancer and inflammatory diseases from natural sources.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $12.5M
About
Develops botanical drug candidates for cancer and inflammatory diseases from natural sources.
Small Molecules
Funding History
2Total raised:$12.5M
Series A$12MMar 15, 2021
Grant$500KMay 15, 2019